日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies

基于既往对高级疗法反应不足或不耐受的Risankizumab疗效和安全性:INSPIRE和COMMAND 3期研究的事后分析

Panaccione, Remo; Louis, Edouard; Colombel, Jean-Frederic; D'Haens, Geert; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Takeuchi, Ken; Rubin, David T; Kalabic, Jasmina; Chien, Karen B; Chen, Su; Cheng, Ling; Zhang, Yafei; Duan, W Rachel; Vladea, Ramona; Hecht, Patrick M; Morisset, Pierre; Schreiber, Stefan; Ferrante, Marc

Efficacy and safety of risankizumab in patients with moderately to severely active Crohn's disease: interim results from the SEQUENCE open-label extension study

利沙珠单抗治疗中重度活动性克罗恩病患者的疗效和安全性:SEQUENCE开放标签扩展研究的中期结果

Peyrin-Biroulet, Laurent; Atreya, Raja; Danese, Silvio; Lindsay, James O; Chapman, J Casey; Anschutz, Toni; Huang, Xiu; Zambrano, Javier; van Haaren, Stijn; Joshi, Namita; Duan, W Rachel; Cross, Raymond K

Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.

Risankizumab治疗溃疡性结肠炎:两项随机临床试验

Louis Edouard, Schreiber Stefan, Panaccione Remo, Bossuyt Peter, Biedermann Luc, Colombel Jean-Frederic, Parkes Gareth, Peyrin-Biroulet Laurent, D'Haens Geert, Hisamatsu Tadakazu, Siegmund Britta, Wu Kaichun, Boland Brigid S, Melmed Gil Y, Armuzzi Alessandro, Levine Phillip, Kalabic Jasmina, Chen Su, Cheng Ling, Shu Lei, Duan W Rachel, Pivorunas Valerie, Sanchez Gonzalez Yuri, D'Cunha Ronilda, Neimark Ezequiel, Wallace Kori, Atreya Raja, Ferrante Marc, Loftus Edward V Jr

Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study

Risankizumab治疗克罗恩病患者的长期安全性和有效性:来自2期开放标签扩展研究的结果

Ferrante, Marc; Feagan, Brian G; Panés, Julián; Baert, Filip; Louis, Edouard; Dewit, Olivier; Kaser, Arthur; Duan, W Rachel; Pang, Yinuo; Lee, Wan-Ju; Gustafson, Dawn; Liao, Xiaomei; Wallace, Kori; Kalabic, Jasmina; D'Haens, Geert R

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial

单独使用Elagolix或联合补充疗法治疗月经过多合并子宫肌瘤的女性:一项随机对照试验

Carr, Bruce R; Stewart, Elizabeth A; Archer, David F; Al-Hendy, Ayman; Bradley, Linda; Watts, Nelson B; Diamond, Michael P; Gao, Jingjing; Owens, Charlotte D; Chwalisz, Kristof; Duan, W Rachel; Soliman, Ahmed M; Dufek, Matthew B; Simon, James A

A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain

一项针对糖尿病周围神经病变疼痛患者的T型钙通道阻滞剂ABT-639的随机、双盲、安慰剂和活性药物对照研究

Ziegler, Dan; Duan, W Rachel; An, Guohua; Thomas, James W; Nothaft, Wolfram

Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers

健康志愿者单次和多次服用钙通道阻滞剂ABT-639后,进行群体药代动力学和尿酸暴露分析

An, Guohua; Liu, Wei; Duan, W Rachel; Nothaft, Wolfram; Awni, Walid; Dutta, Sandeep

Erratum to: population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers

更正:健康志愿者单次和多次服用钙通道阻滞剂 ABT-639 后的群体药代动力学和暴露-尿酸分析

An, Guohua; Liu, Wei; Duan, W Rachel; Nothaft, Wolfram; Awni, Walid; Dutta, Sandeep

An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin

口服TRPV1拮抗剂可减弱UV(B)照射引起的皮肤炎症和正常皮肤的激光辐射热诱发电位和疼痛评分。

Schaffler, Klaus; Reeh, Peter; Duan, W Rachel; Best, Andrea E; Othman, Ahmed A; Faltynek, Connie R; Locke, Charles; Nothaft, Wolfram

Flagellar structure and hyperthermophily: analysis of a single flagellin gene and its product in Aquifex pyrophilus

鞭毛结构与嗜热性:嗜热菌中单个鞭毛蛋白基因及其产物的分析

Behammer, W; Shao, Z; Mages, W; Rachel, R; Stetter, K O; Schmitt, R